Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Mouse BTLA Fc Chimera Protein, CF
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Supplier: R&D Systems™ 3007BT050
This item is not returnable.
View return policy
Description
Measured in a competitive binding assay. When Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV ) is immobilized at 0.1 μg/mL (100 μL/well), Recombinant Mouse BTLA Fc Chimera inhibits 50% binding of biotinylated Recombinant Mouse BTLA Fc Chimera (0.2 μg/mL) at the concentration range of 0.3-1 μg/mL.Specifications
Q32MV9 | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. | |
M.W. (Observed): 60-70 kDa, reducing conditions; M.W. (theoretical): 44 kDa (monomer) | |
50 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
<0.10 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
Reconstitute at 100 μg/mL in sterile PBS. | |
BTLA/CD272 |
Binding Activity | |
151888 | |
BTLA Fc Chimera | |
Mouse myeloma cell line, NS0-derived mouse BTLA protein Mouse BTLA Glu30-Gly176 (Lys173Glu) (N-terminus) Accession # Q32MV9 IEGRMDP Mouse IgG2A (Glu98-Lys330) (C-terminus) | |
Disulfide-linked homodimer | |
Btla | |
Recombinant | |
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction